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Abstract
Vanillin is a well-known food and cosmetic additive and has antioxidant and antimutagenic properties. It has also been
suggested to have antifungal activity against major human pathogenic fungi, although it is not very effective. In this study,
the antifungal activities of vanillin and 33 vanillin derivatives against the human fungal pathogen Cryptococcus neoformans,
the main pathogen of cryptococcal meningitis in immunocompromised patients, were investigated. We found a structural
correlation between the vanillin derivatives and antifungal activity, showing that the hydroxyl or alkoxy group is more
advantageous than the halogenated or nitrated group in benzaldehyde. Among the vanillin derivatives with a hydroxyl or
alkoxy group, o-vanillin and o-ethyl vanillin showed the highest antifungal activity against C. neoformans. o-Vanillin was
further studied to understand the mechanism of antifungal action. We compared the transcriptome of C. neoformans cells
untreated or treated with o-vanillin by using RNA sequencing and found that the compound caused mitochondrial
dysfunction and triggered oxidative stress. These antifungal mechanisms of o-vanillin were experimentally confirmed by the
significantly reduced growth of the mutants lacking the genes involved in mitochondrial functions and oxidative stress
response.
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Introduction
The incidence rates of infectious diseases caused by pathogenic
fungi have been increasing rapidly. Widespread fungal diseases not
only affect plants but also threaten animal and human health, with
morbidity and mortality critically influenced by superficial and
invasive fungal infections [1]. Particular attention has been paid to
invasive fungal infections, which have a high mortality rate of
more than 50%. Each year, at least 1.5 million people die from
invasive fungal infections worldwide [2]. The most frequently
isolated human pathogenic fungi are Cryptococcus, Candida, and
Aspergillus species, which normally cause diseases in patients with
immunodeficiency due to human immunodeficiency virus (HIV)
infections or immunosuppressive medications for organ transplan-
tation. Among these commonly isolated fungal pathogens,
Cryptococcus neoformans causes cryptococcal meningitis and kills at
least 650,000 patients annually throughout the world. Cryptococ-
cal infections have a reported mortality rate of 20–70% [3].
Currently available antifungal agents mostly target DNA and
RNA synthesis, the biosynthesis of the cell wall component 1,3-b-
D-glucan, the ergosterol biosynthetic pathway, or ergosterol itself.
Triazole, which inhibits the ergosterol biosynthetic pathway, is the
most widely used fungistatic agent because of its effectiveness and
safety. Fluconazole has been used extensively to treat superficial
and invasive fungal infections. However, the number of resistant
strains to currently available antifungal agents has increased
dramatically during the last decade [4,5]. The mechanism of
resistant strains is through increased drug efflux or alteration of the
drug target or target pathway, which reduces drug efficacy [6].
Therefore, there is increasing demand for a novel compound to
treat fungal infections.
Plant extracts have been used as an effective source of antifungal
agents. Vanillin (4-hydroxy-3-methylbenzaldehyde) is a good
example, which is a primary component of the vanilla bean
extract. Vanillin has long been used as a flavoring compound and
is generally recognized as safe. Each year, more than 12,000 tons
of vanillin is consumed, but the compound is mainly synthetically
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produced because the naturally derived product is expensive [7].
Because of its safety and long-established use as a food additive, a
number of studies have investigated the potential of vanillin as an
antifungal agent. However, no report has shown promising
efficacy of vanillin against fungi. Lopez-Malo et al. [8] and
Cerrutti and Alzamora [9] suggested a possible use of vanillin as
an antifungal agent in food preservation. However, its inhibitory
concentration was too high to be promising. A recent study by
Faria et al. [10] also found no growth inhibitory activity of vanillin
on nine reference human pathogenic fungal strains of Candida and
C. neoformans.
This study aimed to search for a vanillin derivative that has
strong antifungal efficacy against C. neoformans and to understand
the mechanism of action of the compound. We used C. neoformans
because of its clinical importance, well-annotated genome
sequence, and robust genetic tools. A series of vanillin derivatives,
including hydroxy and alkoxy benzaldehydes, halogenated benz-
aldehydes, and nitrated benzaldehydes, were tested for their
antifungal activity against C. neoformans. We found a structural
correlation between the vanillin derivatives and antifungal activity
against C. neoformans; that is, the hydroxyl or alkoxy group
appeared to be more advantageous than the halogenated or
nitrated group in benzaldehyde. Among the vanillin derivatives
with a hydroxyl or alkoxy group, o-vanillin and o-ethyl vanillin
showed the highest antifungal activities against C. neoformans. We
chose o-vanillin to study the mechanism of action. To date,
numerous studies have successfully used functional genomics
approaches, in particular transcriptome analysis, to identify the
target pathway of currently available antifungal drugs and novel
antifungal candidate drugs [11–14]. We therefore used transcrip-
tome analysis to understand the mechanism of action of o-vanillin.
Global transcript profiles of C. neoformans cells treated with o-
vanillin were obtained using RNA sequencing (RNA-Seq) and
were compared with the transcript profiles of the same strain not
treated with the compound. The results of our transcriptome
analysis suggested that o-vanillin likely acts by significantly
reducing mitochondrial function, which would in turn disrupt
cellular redox-homeostasis in C. neoformans. Our hypothesis was
experimentally confirmed by the observation of hypersensitivity of
the C. neoformans mutants lacking the genes involved in the
oxidative stress response upon treatment with o-vanillin.
Materials and Methods
Strains
The wild-type strain used in this study was Cryptococcus neoformans
var. grubii H99. The cfo1 mutant was constructed as described
elsewhere [15]. The sod1 mutant, sod2 mutant, and ccp1 mutant
were constructed using biolistic transformation of the gene-specific
knock-out cassettes, which were generated using overlapping
polymerase chain reaction (PCR) with primers listed in Table S1
[16]. The positive mutants were selected by PCR, and at least two
independent mutants were used throughout the study. Fungal cells
were routinely grown in YPD medium (1% yeast extract, 2%
bacto-peptone, and 2% glucose) at 30uC. Vanillin and the vanillin
derivatives used in this study were purchased from Tokyo
Chemical Industry (Tokyo, Japan).
Antifungal Drug Sensitivity
To estimate sensitivity to the antifungal drug, the fungal cells
were grown in 3 mL of YPD medium at 30uC overnight with
shaking, and minimal inhibitory concentrations (MIC) were
determined as described elsewhere [17]. To investigate the
susceptibility of the wild-type and mutant strains to H2O2 and o-
vanillin, cells were grown in 3 mL of YPD medium overnight,
washed twice with phosphate-buffered saline (PBS; pH 7.4), and
resuspended in PBS. Cell suspensions were spotted on YPD solid
media with or without H2O2 and with or without o-vanillin. The
plates were incubated at 30uC for 2 days and photographed.
RNA Sequencing and Transcriptome Data Analysis
The wild-type strain was grown at 30uC overnight. The cells
were transferred to 50 mL of YPD medium (final density of
1.06106 cells/mL) with 125 mg/mL o-vanillin (dissolved in
dimethyl sulfoxide (DMSO)) or with DMSO (no drug control),
incubated at 30uC for 3 h with shaking, and harvested for RNA
extraction. Total RNA was extracted using the RiboPureTM-
Yeast Kit (Ambion) following the manufacturer’s instructions.
Contaminating genomic DNA was eliminated by RNase-free
DNase (Invitrogen), the quantity and quality of total RNA were
evaluated using RNA electropherograms (Agilent 2100 Bioanaly-
zer), and the RNA integrity numbers (RIN) were determined [18].
Total RNA (10 mg) from each sample was used as starting material
to prepare sequencing libraries. mRNA was purified with the
Dynabeads mRNA Purification Kit (Life Technologies), and the
resulting mRNA was processed with the Illumina TruSeq RNA
Sample Prep kit v2 (Illumina) following the manufacturer’s
instructions. One lane per sample was used for sequencing with
the Illumina Genome Analyzer IIx (Illumina) to generate
nondirectional, single-ended 36-base pair reads. Quality-filtered
reads were mapped to the reference genome sequence (http://
www.broadinstitute.org/annotation/genome/
cryptococcus_neoformans/MultiHome.html) using CLC Geno-
mics Workbench 4.5 (CLC bio). The relative transcript abundance
was computed by counting the reads per kilobase of exon model
per million mapped sequence reads (RPKM) [19]. Processed data
were deposited in the Gene Expression Omnibus (GEO) database
with accession number GSE52645. Gene ontology (GO) analysis
was performed by assigning GO categories to each gene according
to the Gene Ontology Consortium database [20]. Each gene was
compared to the GO database using BLASTP searches, and the
best hit with an e-value lower than 1025 and a hit coverage of
more than 50% was adopted. A hit map based on log-transformed
fold change values was generated by using TM4: MeV [21].
Quantitative Real-time PCR
Primers for real-time PCR were designed using Primer Express
software 3.0 (Applied Biosystems) and are listed in Table S2. Total
RNA was extracted with the RiboPure-Yeast Kit (Ambion), and
cDNA was synthesized using the RevertAid First Strand cDNA
synthesis Kit (Fermentas). Relative gene expression was quantified
using a 7500 system (Applied Biosystems) based on the 22ggCt
method. TEF2 (CNAG_00044, translation elongation factor 2)
was used as a reference.
Fluorescence-activated Cell Sorting Analysis
To perform flow cytometric analysis, cells were grown in YPD
at 30uC overnight. Cells were diluted to 1.06107 cells/mL in
4.5 mL of YPD containing 125 mg/mL o-vanillin and cultured at
30uC for an additional 2 h. After incubation, 1 mL of cells was
washed twice with PBS (pH 7.4) and resuspended in 1 mL of
YPD. Dihydrorhodamine 123, at a final concentration of 10 mg/
mL, was added, and the cell suspension was incubated for an
additional 30 min. A cell suspension of 50 mL was withdrawn and
mixed with 2 mL of 50 mM Tris-HCl (pH 8.0). Flow cytometry
was performed with 26104 cells, and the results were analyzed
using the FL1 channel with FACSCalibur (BD Biosciences). The
software Flowjo 8.7 was used to process images.
Antifungal Activity of Vanillin Derivatives
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Results
The Vanillin Derivatives showed Antifungal Activity
Thirty-three vanillin derivatives were classified into three
groups: group A includes hydroxy and alkoxy benzaldehydes (1
to 16), group B includes halogenated benzaldehydes (17 to 23),
and group C includes nitrated benzaldehydes (24 to 33) (Figure 1).
To evaluate antifungal activity, we determined the MIC of each
vanillin derivative. As previously reported, vanillin showed a
relatively high MIC value against C. neoformans, suggesting its
minimal antifungal activity [22]. In contrast, the derivatives in
group A displayed relatively low MICs compared to that of
vanillin. Among them, o-vanillin (2) and o-ethyl vanillin (3),
specifically, showed the lowest MICs (4 mg/mL), which was even
lower than that of fluconazole observed in our study, suggesting
that o-vanillin and o-ethyl vanillin have strong antifungal activity
against C. neoformans (Table 1). All other derivatives in group A
displayed some degree of antifungal activity except for the
monohydroxy benzaldehydes (4, 5, 13, 15, and 16), indicating
that hydroxy and alkoxy benzaldehydes are potent antifungal
agents for treatment of cryptococcosis. In contrast, the vanillin
derivatives in group B and group C mainly displayed significantly
high MICs against C. neoformans, suggesting that halogenated and
nitrated benzaldehydes have poor antifungal efficacy. These
results indicated structural correlations between the vanillin
derivatives and the antifungal activity against C. neoformans; thus,
the hydroxyl or alkoxy group would be more advantageous than
the halogenated or nitrated group in benzaldehyde as an
antifungal agent.
o-Vanillin Significantly Altered the Global Transcript
Profiles of C. neoformans
The vanillin derivative o-vanillin showed strong antifungal
activity, and we selected this derivative to further study and
determine the inhibitory mechanism against C. neoformans. We
analyzed transcriptome changes in the fungal cells treated with o-
vanillin using RNA-Seq. As mentioned above, transcriptome
analysis has been successfully used in a number of other studies to
define the target pathway and mechanism of action of antifungal
drugs [11,12,23]. To determine the concentration of o-vanillin for
the culture conditions for the transcriptome analysis, we analyzed
the viability of the cells grown in the presence of the compound by
measuring colony-forming units (CFUs). Interestingly, unlike
fungistatic agent fluconazole, o-vanillin displayed fungicidal
activity and no colony was observed at concentrations above
512 mg/mL (Figure 2). We should note that CFU and transcrip-
tome analyses were performed using YPD medium rather than
minimal RPMI medium, which was used for MIC determination
in the present study. The final concentration of 128 mg/mL, at
which viability was reduced by at least 50%, was selected as the
concentration for the cultures for transcriptome analysis.
Figure 1. Vanillin and vanillin derivatives tested in this study. Compounds 1 to 16 are hydroxy and alkoxy benzaldehydes. Compounds 17 to
23 are halogenated benzaldehydes, and compounds 24 to 33 are nitrated benzaldehydes.
doi:10.1371/journal.pone.0089122.g001
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The wild-type C. neoformans cells were grown in the presence or
absence of o-vanillin, and cDNA libraries were constructed using
mRNA purified from each culture and sequenced (see Materials
and Methods). In total, 71,548,744 sequence reads were obtained
from the cDNA libraries, and of these, 68,956,992 (96.37%)
sequence reads were mapped against the genome of C. neoformans
var. grubii H99 (Figure 3). o-Vanillin treatment altered the
transcript levels of 1,994 genes by more than 2-fold. Among the
differentially expressed genes, 665 and 245 genes were up- and
down-regulated by more than 3-fold, respectively, indicating the
substantial effect of o-vanillin on the transcriptome of C. neoformans
(Table S3). A subset of these differentially expressed genes were
selected, and changes of their transcript levels were confirmed by
quantitative real-time PCR (Q-RT-PCR) (Figure 4).
Our RNA-Seq analysis showed the transcript levels of 6,980
genes in the genome of C. neoformans. Among these, 4,067 genes
were categorized based on GO terms. We used these GO terms, in
particular biological processes, to define the possible target cellular
processes of o-vanillin. We focused on GO terms that were highly
enriched within the up-regulated genes upon treatment with o-
vanillin because a number of previous transcriptome analyses
suggested that the genes in the putative target pathway of an
antifungal drug tend to be up-regulated upon treatment for
compensation; for example, fluconazole treatment increases the
transcript levels of the genes in the ergosterol biosynthesis
pathway. As shown in Table 2, the GO term ‘oxidation-reduction
process’ was the most highly enriched among the genes up-
regulated by o-vanillin treatment, implying that the redox status in
C. neoformans was substantially influenced by o-vanillin. We also
observed that the genes with the GO terms ‘transmembrane
transport’ and ‘proteolysis’ were highly enriched. The genes with
transmembrane transport are mainly involved in efflux functions,
suggesting that the fungal cells highly express membrane
transporters to remove the toxic antifungal compound from the
intracellular environment. In addition, enrichment of the GO
term ‘proteolysis’ may indicate that the cells are under oxidative
stress, since protein quality control and proteolysis mechanisms are
involved in oxidative stress response in Saccharomyces cerevisiae [24].
Table 1. Antifungal activity of vanillin and 33 vanillin
derivatives against C. neoformans.
Compound MIC (mg/mL)
Vanillin .128


































1Group A was for hydroxy and alkoxy benzaldehydes;
2Group B was for halogenated benzaldehydes;
3Group C was for nitrated benzaldehydes.
doi:10.1371/journal.pone.0089122.t001
Figure 2. Viability of C. neoformans in the presence of o-vanillin.
The fungal cells were grown in YPD media containing different
concentrations of o-vanillin or fluconazole as indicated, and incubated
at 30uC. Viability of the cells were determined by measuring CFUs after
2 days. Fluconazole was included as a control.
doi:10.1371/journal.pone.0089122.g002
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o-Vanillin Triggered Oxidative Stress in C. neoformans
The results of the transcriptome analysis showed that the most
significantly affected cellular process by o-vanillin is cellular redox
homeostasis. An imbalance in cellular redox homeostasis is often
caused by oxidative stress, and therefore, we hypothesized that a
similar stress was triggered by o-vanillin in C. neoformans. We
predicted that the C. neoformans mutants that showed increased
sensitivity to oxidative stress would grow more slowly than the wild
type in the presence of o-vanillin if the compound indeed induces a
similar stress. To confirm this hypothesis, we constructed mutants
lacking SOD1 or SOD2, which encode copper-zinc-dependent
cytosolic superoxide dismutase (CuZn-SOD) and manganese-
dependent mitochondrial superoxide dismutase (Mn-SOD), re-
spectively. The mutant lacking the gene CFO1, which encodes
membrane ferrioxidase and is hypersensitive to oxidative stress due
to reduced mitochondrial function, was also included in the
experiment [23,25]. Moreover, the mutant lacking SIT1, which
encodes the siderophore transporter and was shown to be
independent of oxidative stress defense, was included as a negative
control strain [26].
The growth of the mutants lacking SOD1, SOD2, CFO1, or SIT1
in the presence of hydrogen peroxide (H2O2; an oxidative stress-
inducing agent) or o-vanillin was monitored. We first confirmed
the results of a previous report that showed that hydrogen
peroxide significantly inhibits the growth of both the sod2 mutant
and the cfo1 mutant (Figure 5A) [23,27]. The growth of the sod1
Figure 3. Sequence read mapping statistics. The number of the
sequence reads mapped to the reference genome (Cryptococcus
neoformans var. grubii H99). In total, 96.37% sequence reads were
mapped against the genome of C. neoformans.
doi:10.1371/journal.pone.0089122.g003
Figure 4. Confirmation of RNA-Seq data by quantitative RT-PCR (Q-RT-PCR). Eight genes were selected, and their transcript levels were
quantified by Q-RT-PCR. Results of Q-RT-PCR are illustrated in parallel with the RNA-Seq data, and showed identical patterns. Data are averages from
three independent experiments with three biological replicates, normalized by TEF2 as an internal control, and presented as relative expression levels
in comparison to the transcript levels in the cells cultured in the absence of o-vanillin. Bars represent standard deviations.
doi:10.1371/journal.pone.0089122.g004
Table 2. Enrichment of GO terms for the biological
processes*.




carbohydrate metabolic process 13
regulation of transcription from RNA polymerase II promoter 12
regulation of transcription, DNA-dependent 9
pentose-phosphate shunt 5




*Genes that were up-regulated more than 3-fold by o-vanillin treatment were
analyzed for enrichment of GO terms of the biological processes. GO terms that
contains at least 3 count (genes) were shown.
doi:10.1371/journal.pone.0089122.t002
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mutant and the sit1 mutant was not inhibited, as previously
reported [26]. We next challenged the same mutant sets with o-
vanillin and found that the sod2 mutant and the cfo1 mutant
displayed significantly increased sensitivity to the compound, while
the sod1 mutant and the sit1 mutant showed no changes in growth
phenotype compared to the wild type (Figure 5B). These results
suggest that o-vanillin triggers oxidative stress, which leads to the
disruption of cellular redox homeostasis in C. neoformans.
o-Vanillin Caused Mitochondrial Dysfunction in C.
neoformans
Previously, several independent studies suggested that the sod2
mutant and the cfo1 mutant had substantial depletion of
mitochondrial functions, which mainly accounts for the increased
susceptibility of the mutants to oxidative stress [23,25]. We
therefore analyzed the obtained transcriptome data focusing on
the genes that were predicted to encode mitochondrial proteins.
The C. neoformans genome contains at least 221 genes that are
predicted to encode mitochondrial proteins, and the transcriptome
data showed that many of these genes were differentially expressed
following o-vanillin treatment. Among these 221 genes, the
transcript levels of 62 genes were altered by o-vanillin treatment
by at least 2-fold (Table S4), which further confirmed our
hypothesis that o-vanillin substantially influences mitochondrial
functions in C. neoformans.
One of the main cellular functions of mitochondria is energy
production by oxidative respiration through the tricarboxylic acid
(TCA) cycle and the electron transport chain. We predicted that
the TCA cycle and the electron transport chain might be
significantly distorted if the mitochondrial functions were affected
by o-vanillin treatment. To confirm this hypothesis, we specifically
focused on alterations in transcript levels of the genes encoding
proteins required for the TCA cycle and the electron transport
chain. As expected, the transcript levels of the genes required for
both the TCA cycle and the electron transport chain were
significantly reduced by o-vanillin. In particular, the genes
required for the electron transport chain showed profound
down-regulation, suggesting that o-vanillin mainly affects the
mitochondrial electron transport chain. We also took advantage of
the previously reported transcriptome data of the cfo1 mutant,
which showed significantly reduced mitochondrial respiration
[23]. The obtained transcript profiles of the genes required for
respiration were aligned with the previously derived transcriptome
data from the cfo1 mutant, and a clustering analysis was performed
to compare the patterns of changes in the transcript levels of the
genes. Results of this analysis showed highly similar patterns of
down-regulation in the genes involved in the TCA cycle and the
electron transport chain between the o-vanillin treated cells and
the cfo1 mutant (Figure 6).
We further investigated depletion of mitochondrial function by
o-vanillin using dihydrorhodamine 123, which is a fluorescent dye
that stains mitochondria in living cells. The damaged mitochon-
dria retained much less dihydrorhodamine 123 than did the
healthy mitochondria. We treated the fungal cells with o-vanillin
and dihydrorhodamine 123 and analyzed the fluorescence
intensity by fluorescence-activated cell sorting (FACS). The
observation of fluorescence profiles indicated that dihydrorhoda-
mine 123 accumulated less in the cells treated with o-vanillin than
in untreated cells, suggesting that mitochondrial functions were
damaged by the compound (Figure 7A). Our results were also
supported by the observation of less accumulation of dihydrorho-
damine 123 in the cfo1 mutant and the ccp1 mutant (Figure 7B),
which displayed significantly reduced mitochondrial function.
Taken together, the results of the present study suggest that o-
vanillin has antifungal activity against C. neoformans and substan-
tially distorts mitochondrial functions, resulting in an overall
deficiency of oxidative stress defense mechanisms in C. neoformans.
Therefore, o-vanillin can be an effective drug candidate to treat
cryptococcosis.
Discussion
In this study, we investigated the antifungal activity of vanillin
and its derivatives, which were classified into three groups
(hydroxy and alkoxy benzaldehydes, halogenated benzaldehydes,
and nitrated benzaldehydes), and determined their antifungal
activity against C. neoformans. Our results suggested a structural
correlation between the compounds and antifungal activity. Most
of the hydroxy and alkoxy benzaldehydes showed strong
antifungal activity, while the halogenated benzaldehyde and
nitrated benzaldehyde compounds showed no activity. o-Vanillin
and o-ethyl vanillin belong to the hydroxy and alkoxy benzalde-
hydes group, and showed the highest antifungal activity among all
tested compounds of this group. We used o-vanillin to further study
the mechanism of antifungal action. We obtained global transcript
profiles of the wild type cells grown in the presence or absence of o-
vanillin by RNA Seq, and analyzed the data using GO functional
categories. The results of the transcriptome analysis revealed that
o-vanillin mainly disrupts redox homeostasis in C. neoformans, and
that the fungal cells undergo oxidative stress induced by the
compound.
Reactive oxygen species (ROS), such as superoxide anion
(O?2
2), hydroxyl radical (OH?), and hydrogen peroxide (H2O2),
are byproducts of aerobic respiration; they trigger oxidative stress,
which detrimentally affects multiple cellular processes. ROS are
also involved in host-pathogenic microbe interactions. The host
phagocyte produces ROS to inhibit and remove the intracellular
pathogens; however, pathogenic microbes have well-developed
Figure 5. Mutants that have increased sensitivity to oxidative
stress and reduced mitochondrial functions are highly sensi-
tive to o-vanillin. The sensitivity of the wild type, cfo1 mutant, and
sod2 mutant to H2O2 (A) and o-vanillin (B) was investigated by
monitoring the growth of the strains in media containing each
compound. Cells at 10-fold serial dilutions (starting at 104 cells) were
spotted onto plates, incubated at 30uC for 2 days, and photographed.
doi:10.1371/journal.pone.0089122.g005
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defense mechanisms to survive under oxidative stress. C. neoformans
is no exception, and the fungus utilizes enzymes such as superoxide
dismutases, cytochrome c peroxidase, and thiol-peroxidases to
cope with oxidative stress within the host phagocyte [27–30].
Oxidative stress within mitochondria has also been reported to
increase the sensitivity of the fungus to azole antifungal drugs [23].
Thus, the oxidative stress response and mitochondrial functions
play critical roles in the physiology and pathogenesis of C.
neoformans. The present study revealed that the fungicidal activity
of o-vanillin involves the induction of oxidative stress and reduced
mitochondrial functions, which is supported by our transcriptome
analysis results and phenotypic observations of the mutants lacking
SOD2 and CFO1. In C. neoformans, mitochondrial Mn-SOD, which
is encoded by SOD2, has been suggested to be responsible for
redox homeostasis in mitochondria, and the absence of Mn-SOD
activity causes substantial damage to mitochondrial DNA,
proteins, and lipids. Indeed, the sod2 mutant showed increased
sensitivity to oxidative stress, reduced growth at the host body
temperature of 37uC compared to the wild type, and avirulence in
a murine inhalation model of cryptococcosis [27]. Mitochondrial
functions were also influenced by deletion of CFO1 in C. neoformans.
The mutant lacking CFO1 showed reduced mitochondrial
respiration and increased sensitivity to oxidative stress and azole
antifungal drugs [23]. These previous findings and the results from
this study strongly support our conclusion that o-vanillin induces
oxidative stress and disrupts mitochondria functions in C. neofor-
mans. Interestingly, a previous study by Kim et al. [31] showed
that vanillin and the vanillin derivatives vanillic acid and vanillyl
acetone also trigger oxidative stress within mitochondria and
inhibit the growth of S. cerevisiae, Aspegillus flavus, and A. fumigatus.
Despite its complex nature, the fungal mitochondrion has been
considered an effective drug target for treatment of fungal
infections. C. neoformans and C. albicans, the most prevalent human
fungal pathogens, are petite negative, and a number of studies
suggested tight connections between mitochondrial functions and
virulence in these fungi. As mentioned above, the mutant lacking
SOD2, which encodes mitochondrial Mn-SOD, showed reduced
virulence [25]. Moreover, global transcriptome analysis by serial
analysis of gene expression (SAGE) during colonization of C.
neoformans in the host central nervous system showed that an
increase in mitochondrial respiration functions is required for
disease progression [32]. The involvement of mitochondria in
virulence was also reported in a study with another Cryptococcus
species, C. gattii, which caused the Vancouver Island and North
American outbreaks, and typically infects immunocompetent
individuals. Hypervirulent C. gattii strains were found to have
high expression of genes within the mitochondrial genome and up-
regulated mitochondrial functions [33]. Similarly, several studies
showed the effects of dysfunctional mitochondria in C. albicans. For
example, deficiency of mitochondrial functions by deletion of the
mitochondrial protein-encoding gene GOA1 in C. albicans caused
not only decreased respiration and mitochondrial membrane
potential but also loss of virulence in a murine model of
disseminated candidiasis [34]. Furthermore, the absence of
Sam37, which is the mitochondrial outer membrane sorting and
assembly machinery (SAM) complex subunit, rendered C. albicans
avirulent [35]. In addition, the close association between cell wall
and membrane integrity makes mitochondrial functions an
attractive target for novel antifungal treatment. Tetracyclin
treatment caused dysfunction of mitochondria, which reduced
ergosterol levels in the cell membrane and thus increased the
sensitivity of C. neoformans and C. albicans to amphotericin B [36].
The influence of mitochondrial deficiency on cell wall integrity
was also suggested by a study evaluating a collection of S. cerevisiae
mitochondrial mutants and a C. albicans mutant lacking CCR4/
POP2, which encodes mRNA deadenylase and regulates mito-
chondrial functions and phospholipid homeostasis [37]. Several
drug candidates that inhibit mitochondrial functions in fungi have
been proposed. An amino acid-derived 1,2-benzisothiazolinone
(DFD-VI-15) showed inhibitory effects on fungal mitochondria,
and the compound showed fungicidal activity against C. neoformans
and C. albicans [38]. Other compounds that inhibit mitochondrial
functions of the pathogenic fungi include 3-hydroxy oxylipins,
acetylsalicylic acid, and the arylamidine compound T-2307
Figure 6. o-Vanillin causes differential expression of the genes involved in respiration. Genes related to cellular respiration (glycolysis, the
TCA cycle, and the electron transport chain) were selected from our transcriptome data and compared with the previous transcriptome data derived
from a study with the cfo1 mutant. The results are represented by the hip-map, and the asterisk indicates that the genes required for the electron
transport chain were more significantly down-regulated by o-vanillin.
doi:10.1371/journal.pone.0089122.g006
Figure 7. Mitochondrial functions were altered by o-vanillin
treatment. (A) The results of FACS analysis showed that dihydrorho-
damine 123 accumulated less in the o-vanillin treated cells than in the
untreated cells. (B) The cfo1 mutant and the ccp1 mutant, which were
shown to have abnormal mitochondrial functions in previous studies
[23,28], also showed less accumulation of dihydrorhodamine 123 and
were included as controls.
doi:10.1371/journal.pone.0089122.g007
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[39,40]. These previous studies investigating a series of antifungal
drug candidates demonstrated that mitochondria are an attractive
antifungal target, and support our conclusion that o-vanillin can be
an effective antifungal drug candidate. o-Vanillin triggered
mutations in Escherichia coli when it was treated with N-methyl-
N’-nitro-N-nitrosoguanidine (MNNG) or N-methyl-N-nitrosourea
[41], and treatment of Chinese hamster ovary cells with 400 mg/
mL o-vanillin for 2 h in the presence of MNNG caused structural
chromosome aberrations [42]. However, possible toxic effects
could be eliminated because o-vanillin itself is not a clastogen, and
thus no toxicity of the compound itself has been reported [42].
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